Skip to main content
. Author manuscript; available in PMC: 2015 Mar 6.
Published in final edited form as: Br J Nutr. 2013 Sep 24;111(4):679–689. doi: 10.1017/S0007114513002985

Table 5. Sex differences in change in EPA and DHA in plasma fractions, cells and AT following 12-months supplementation with EPA+DHA.

EPA1 P 2 DHA1 P 2
Plasma PC −0.07 [−0.37, 0.22] 0.63 −0.16 [−0.62, 0.30] 0.50
Plasma CE −0.16 [−0.43, 0.11] 0.25 0.08 [−0.02, 0.12] 0.10
Plasma NEFA 0.04 [−0.06, 0.15] 0.42 0.23 [−0.22, 0.69] 0.79
Plasma TAG −0.30 [−0.60, −0.01] 0.05 −0.21 [−0.56, 0.14] 0.25
MNC −0.16 [−0.42, 0.11] 0.26 0.03 [−0.22, 0.29] 0.82
RBC −0.51 [−1.40, 0.37] 0.26 0.36 [−0.18, 0.90] 0.19
PLAT −0.25 [−0.53, 0.03] 0.08 −0.09 [−0.29, 0.11] 0.38
BU −0.10 [−2.01, 1.82] 0.93 0.07 [−0.11, 0.26] 0.44
AT 0.02 [−0.02, 0.06] 0.25 0.00 [−0.05, 0.05] 0.99
1

Data are mean difference [95% CI] in the change in EPA or DHA expressed as percentage of total fatty acids female compared to male adjusted for treatment group, compliance and BMI.

2

Analysis is change regressed on male vs. female, adjusted for treatment group, compliance and BMI.